Craig B. Lipkin
Craig B. Lipkin publishes mostly in Cardiology and Cardiovascular Medicine, Hematology and Epidemiology, on topics such as Acute Myeloid Leukemia Research, Antiplatelet Therapy and Cardiovascular Diseases and Neutropenia and Cancer Infections.
- World rank
- #5,317,873 of 7,710,434 ranked researchers
- Rank in United States
- #1,355,416 of 1,627,098
- Works
- 55
- Citations
- 660
- Citations per work
- 12.0
What does Craig B. Lipkin research?
Craig B. Lipkin's work is mostly in Medicine (58%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3258.0%
- Medicine3258.0%
- Everything else2342.0%
- 1Cardiology and Cardiovascular Medicine18% of their works
- 2Hematology12% of their works
- 3Epidemiology10% of their works
- 4Oncology7% of their works
- 5Public Health, Environmental and Occupational Health6% of their works
- 6Surgery5% of their works
Research topics
- Acute Myeloid Leukemia Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Neutropenia and Cancer Infections
- Substance Abuse Treatment and Outcomes
- Hematopoietic Stem Cell Transplantation
- Atrial Fibrillation Management and Outcomes
- Venous Thromboembolism Diagnosis and Management
- Acute Lymphoblastic Leukemia research
Which keywords describe Craig B. Lipkin's research?
The keywords of their largest research topics: Hematopoietic Stem Cells, Prognostic Factors, Prophylaxis, Acute Myeloid Leukemia, AML, Aspirin, Clopidogrel and Antimicrobial Agents.
- Childhood Cancer
- Antithrombotic Therapy
- Acute Lymphoblastic Leukemia
- Graft-versus-Host Disease
- Alcohol Dependence
- Antimicrobial Agents
- Aspirin
- AML
- Prognostic Factors
- Hematopoietic Stem Cells
- Prophylaxis
- Acute Myeloid Leukemia
- Clopidogrel
- Febrile Neutropenia
- Bone Marrow Niche
- Substance Use Disorders
- Anticoagulant Therapy
- Atrial Fibrillation
- Venous Thromboembolism
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Hematopoietic Stem Cells162 topics
- Prognostic Factors152 topics
- Prophylaxis132 topics
- AML101 topic
- Acute Myeloid Leukemia101 topic
- Aspirin91 topic
- Clopidogrel91 topic
- Antimicrobial Agents81 topic
- Febrile Neutropenia81 topic
- Alcohol Dependence61 topic
- Bone Marrow Niche61 topic
- Graft-versus-Host Disease61 topic
- Substance Use Disorders61 topic
- Acute Lymphoblastic Leukemia51 topic
- Anticoagulant Therapy51 topic
- Antithrombotic Therapy51 topic
- Atrial Fibrillation51 topic
- Childhood Cancer51 topic
- Venous Thromboembolism51 topic
Where does Craig B. Lipkin work?
Craig B. Lipkin's main affiliation in the publication record is Premier Research Group, United States.
How many publications and citations does Craig B. Lipkin have?
OpenAlex counts 55 works and 660 citations for Craig B. Lipkin, an h-index of 12, ranking #5,317,873 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Craig B. Lipkin. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.